OXA-01
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 407427

CAS#: 936889-68-8

Description: OXA-01 is an inhibitor of both mTORC1 and mTORC2 (IC50s = 11 and 29 nM, respectively). OXA-01 targeted both mTORC1 and mTORC2 signaling in vitro and in vivo. OXA-01 reduced VEGF production in tumors in a manner associated with decreased vessel sprouting but little vascular regression.


Chemical Structure

img
OXA-01
CAS# 936889-68-8

Theoretical Analysis

MedKoo Cat#: 407427
Name: OXA-01
CAS#: 936889-68-8
Chemical Formula: C21H20ClN5O2
Exact Mass: 409.1306
Molecular Weight: 409.874
Elemental Analysis: C, 61.54; H, 4.92; Cl, 8.65; N, 17.09; O, 7.81

Price and Availability

Size Price Availability Quantity
5.0mg USD 290.0 2 Weeks
10.0mg USD 500.0 2 Weeks
25.0mg USD 900.0 2 Weeks
Bulk inquiry

Synonym: OXA-01; OXA01; OXA 01.

IUPAC/Chemical Name: trans-4-[8-amino-1-(7-chloro-1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]-cyclohexanecarboxylic acid

InChi Key: UXCAKZGNKOZXBM-HAQNSBGRSA-N

InChi Code: InChI=1S/C21H20ClN5O2/c22-14-3-1-2-13-10-15(25-16(13)14)17-18-19(23)24-8-9-27(18)20(26-17)11-4-6-12(7-5-11)21(28)29/h1-3,8-12,25H,4-7H2,(H2,23,24)(H,28,29)/t11-,12-

SMILES Code: O=C([C@H]1CC[C@H](C2=NC(C(N3)=CC4=C3C(Cl)=CC=C4)=C5C(N)=NC=CN52)CC1)O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 409.874 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Bhagwat SV, Gokhale PC, Crew AP, Cooke A, Yao Y, Mantis C, Kahler J, Workman
J, Bittner M, Dudkin L, Epstein DM, Gibson NW, Wild R, Arnold LD, Houghton PJ,
Pachter JA. Preclinical characterization of OSI-027, a potent and selective
inhibitor of mTORC1 and mTORC2: distinct from rapamycin. Mol Cancer Ther. 2011
Aug;10(8):1394-406. doi: 10.1158/1535-7163.MCT-10-1099. PubMed PMID: 21673091.

2: Falcon BL, Barr S, Gokhale PC, Chou J, Fogarty J, Depeille P, Miglarese M,
Epstein DM, McDonald DM. Reduced VEGF production, angiogenesis, and vascular
regrowth contribute to the antitumor properties of dual mTORC1/mTORC2 inhibitors.
Cancer Res. 2011 Mar 1;71(5):1573-83. doi: 10.1158/0008-5472.CAN-10-3126. PubMed
PMID: 21363918; PubMed Central PMCID: PMC3077087.

OXA-01

5.0mg / USD 290.0